-
Taxonomy & unit
-
us-gaap: CAD and USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
Intellipharmaceutics International Inc. annual/quarterly Net Income (Loss) Attributable to Parent history and growth rate from Q1 2016 to Q2 2017.
- Intellipharmaceutics International Inc. Net Income (Loss) Attributable to Parent for the quarter ending May 31, 2017 was -CA$1.81M, a 9.74% increase year-over-year.
- Intellipharmaceutics International Inc. annual Net Income (Loss) Attributable to Parent for 2018 was -CA$13.7M, a 55.2% decline from 2017.
- Intellipharmaceutics International Inc. annual Net Income (Loss) Attributable to Parent for 2017 was -CA$8.86M, a 12.7% increase from 2016.
- Intellipharmaceutics International Inc. annual Net Income (Loss) Attributable to Parent for 2016 was -CA$10.1M, a 36.4% decline from 2015.
Net Income (Loss) Attributable to Parent, Quarterly (CAD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)